Patents by Inventor Rainer B. Lanz

Rainer B. Lanz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic/prognostic marker and therapeutic target for cancer
    Patent number: 10227656
    Abstract: Embodiments of the present disclosure concern methods and compositions for prognosis, diagnosis, and/or treatment of prostate cancer or breast cancer, for example. Certain embodiments of the disclosure concern assaying for the expression level of TDRD1. Particular embodiments concern treating an individual with a particular cancer therapy when the expression level of TDRD1 is overexpressed.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: March 12, 2019
    Assignee: Baylor College of Medicine
    Inventors: Bin He, Rainer B. Lanz, Nicholas Mitsiades, Qin Feng
  • A NOVEL DIAGNOSTIC/ PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR CANCER
    Publication number: 20160281170
    Abstract: Embodiments of the present disclosure concern methods and compositions for prognosis, diagnosis, and/or treatment of prostate cancer or breast cancer, for example. Certain embodiments of the disclosure concern assaying for the expression level of TDRDl. Particular embodiments concern treating an individual with a particular cancer therapy when the expression level of TDRDl is overexpressed.
    Type: Application
    Filed: November 7, 2014
    Publication date: September 29, 2016
    Inventors: Bin He, Rainer B. Lanz, Nicholas Mitsiades, Qin Feng